Taken together, the discovery of cellular and molecular targets modulated by the tumor suppressor miR-28-5p and its upstream regulator TRPM7 molecule provides key insights into the potential mechanisms of glioma tumorigenesis and suggests novel therapeutic targets for glioma treatments. The gene discussed is TRPM7; the disease is central nervous system cancer.